News summary

XtalPi Debuts Kodexia™, the World

Source: PR Newswire • Published: 06 Oct 2026, 14:42

Summarized by Masters of Longevity from PR Newswire.

A news article describing a new integrated siRNA discovery platform that combines AI, mechanistic modeling, and automated labs to accelerate nucleic acid therapeutic programs.

XtalPi Debuts Kodexia™, the World
Key Takeaways
  • Kodexia™ integrates generative AI, mechanistic RNA modeling, and automated labs into a closed-loop siRNA discovery workflow.
  • Internal benchmarking showed Kodexia™ achieved nearly threefold higher molecular design efficiency than conventional workflows.
  • More than 50% of first-round designs demonstrated stronger in vivo activity than positive controls across multiple programs.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.